Gary Stuart Tilbrook
23Patents
9h-index
11Co-inventors
72Inventor score
Filing activity: Mar 7, 1994 → Jul 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USD793899S1 | Gemstone | General | 24 | Active |
| US9156842B2 | Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-YL]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process | Chemistry; Metallurgy | 19 | Active |
| US9193730B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 18 | Active |
| US5480894A | 3-hydroxypyridin-4-one derivatives as chelating agents | Human Necessities | 16 | Expired |
| US9512078B2 | Process for preparing 3-[(45)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process | Chemistry; Metallurgy | 15 | Active |
| US8642588B2 | Short-acting benzodiazepine salts and their polymorphic forms | Human Necessities | 14 | Active |
| US9561236B2 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Human Necessities | 10 | Active |
| US9737547B2 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Human Necessities | 10 | Active |
| US9827251B1 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Human Necessities | 9 | Active |
| US9777007B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 8 | Active |
| US6506911B2 | Pyrano [3,2-d]-1,3-dioxin-8 ones | Chemistry; Metallurgy | 6 | Expired |
| US9914738B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 4 | Active |
| US10472365B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 3 | Active |
| US10052334B2 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Human Necessities | 3 | Active |
| US6335353B1 | Orally active iron (III) chelators | Chemistry; Metallurgy | 3 | Expired |
| US10195210B2 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Human Necessities | 3 | Active |
| US10342800B2 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Human Necessities | 2 | Active |
| US10722522B2 | Dosing regimen for sedation with CNS 7056 (remimazolam) | Human Necessities | 1 | Active |
| US12365684B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 0 | Active |
| US6448273B1 | Orally active iron (III) chelators | Chemistry; Metallurgy | 0 | Expired |
| US10961250B2 | Short-acting benzodiazepine salts and their polymorphic forms | Chemistry; Metallurgy | 0 | Active |
| US12201637B2 | Dosing regimen for sedation with CNS 7056 (Remimazolam) | Human Necessities | 0 | Active |
| US10000464B2 | Process for preparing 3-[(4S)-8-bromo-1-methyl-6-(2-pyridinyl)-4H-imidazo[1,2-A][1,4]benzodiazepine-4-yl]propionic acid methyl ester or the benzene sulfonate salt thereof, and compounds useful in that process | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.